Details for New Drug Application (NDA): 022377
✉ Email this page to a colleague
The generic ingredient in ALSUMA is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
Summary for 022377
Tradename: | ALSUMA |
Applicant: | Meridian Medcl |
Ingredient: | sumatriptan succinate |
Patents: | 1 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | ||||
Approval Date: | Jun 29, 2010 | TE: | RLD: | No | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Aug 26, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | ACUTE TREATMENT OF MIGRAINE ATTACKS, WITH OR WITHOUT AURA, AND THE TREATMENT OF CLUSTER HEADACHE EPISODES |
Complete Access Available with Subscription